The delayed emptying from GLP-1 medications is medication-induced and temporary
Among patients with a prior history of CUD, semaglutide was associated with a lower, but not statistically significant, risk of recurrent CUD and the strength of the association attenuated over time (Fig
Many NGP candidates are significant contributors to butyrate and propionate pools, thereby supplying energy substrates for colonocytes, enhancing epithelial barrier function, and exerting epigenetic and anti-inflammatory effects through HDAC inhibition and G-proteincoupled receptor signaling (96)
[12] [20] Lesin renal aguda: Puede ocurrir secundaria a deshidratacin por efectos gastrointestinales severos
An additional feature that distinguishes orforglipron from other oral GLP-1 therapies is its lack of food and water restrictions
Tirzepatide has been used safely for years in medical practice